F.A. Fitzpatrick
- Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology 11
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects 34
- Pharmacogenetics and Drug Metabolism 6
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects 34
- Pharmacogenetics and Drug Metabolism 6
- Physiology top 2%
- Asthma and respiratory diseases 16
- Cancer Research top 5%
-
- Antiplatelet Therapy and Cardiovascular Diseases 10
-
- Peptidase Inhibition and Analysis 9
-
- Analytical Chemistry and Chromatography 6
-
- Estrogen and related hormone effects 6
- Co-authors
- Michael A. WynaldaStephen M. PrescottPhilip J. MoosRobert A. LepleyLars ÖrningR.C. MurphyKornelia EdesRoy J. Soberman
- Cited by
- BiochemistryPharmacology
- Journals
- Journal of Biological Chemistry (14 papers)Prostaglandins (7 papers)Analytical Chemistry (7 papers)
- Partner nations
- United StatesSwedenFrance
In The Last Decade
F.A. Fitzpatrick
97 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 130
- Biochemistry 887
- Pharmacology 1.4k
- Pharmacology 350
- Physiology 1.0k
- Cancer Research 422
Countries citing papers authored by F.A. Fitzpatrick
This map shows the geographic impact of F.A. Fitzpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.A. Fitzpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.A. Fitzpatrick more than expected).
Fields of papers citing papers by F.A. Fitzpatrick
This network shows the impact of papers produced by F.A. Fitzpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.A. Fitzpatrick. The network helps show where F.A. Fitzpatrick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F.A. Fitzpatrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 21 | |
| 2 | 2010 | 65 | |
| 3 | 2008 | 49 | |
| 4 | 2001 | 120 | |
| 5 | 2001 | 106 | |
| 6 | 2000 | 423 | |
| 7 | 1997 | 33 | |
| 8 | 1996 | 119 | |
| 9 | 1995 | 23 | |
| 10 | 1995 | 2 | |
| 11 | 1994 | 12 | |
| 12 | 1994 | 6 | |
| 13 | 1994 | 7 | |
| 14 | 1992 | 5 | |
| 15 | 1992 | 55 | |
| 16 | 1991 | 5 | |
| 17 | 1988 | 5 | |
| 18 | 1982 | 28 | |
| 19 | 1982 | 18 | |
| 20 | Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon. | 1981 | 63 |
About F.A. Fitzpatrick
F.A. Fitzpatrick is a scholar working on Pharmacology, Biochemistry and Physiology, having authored 99 papers that have together received 4.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (34 papers), Asthma and respiratory diseases (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Peptidase Inhibition and Analysis (9 papers), Analytical Chemistry and Chromatography (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Estrogen and related hormone effects (6 papers). The work is most often cited by research in Biochemistry (887 citations), Pharmacology (1.4k citations) and Pharmacology (350 citations). F.A. Fitzpatrick has collaborated with scholars based in United States, Sweden and France. Frequent co-authors include Michael A. Wynalda, Stephen M. Prescott, Philip J. Moos, Robert A. Lepley, Lars Örning, R.C. Murphy, Kornelia Edes, Roy J. Soberman, James E. Mullally and J McGee. Their work appears in journals such as Journal of Biological Chemistry, Prostaglandins, Analytical Chemistry, Proceedings of the National Academy of Sciences and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.